Rivaroxaban for treating chronic heart failure [ID1462]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Artificial Intelligence assisted Echocardiography to support diagnosis of heart failure: Early Value AssessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Extra-vascular implantable cardioverter defibrillator (EVICD) for people with a defibrillatorStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and hyperlipidaemia [ID6559]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC